Am80, a retinoic acid receptor agonist, activates the cardiomyocyte cell cycle and enhances engraftment in the heart
Stem Cell Reports · 2023
DOI: 10.1016/j.stemcr.2023.06.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2023. Verfasst von Manabu Kasamoto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for iPS Cell Research and Application, Kyoto University, Kyoto, Japan; Department of Cardiovascular Medicine, Kyoto University Hospital, Kyoto…. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Takeda Pharmaceutical Company, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science London.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for iPS Cell Research and Application, Kyoto University, Kyoto, Japan; Department of Cardiovascular Medicine, Kyoto University Hospital, Kyoto, Japan.
- Centre for iPS Cell Research and Application, Kyoto University, Kyoto, Japan; Takeda-CiRA Joint program (T-CiRA), Fujisawa, Japan. Electronic address: s.funakoshi@cira.kyoto-u.ac.jp.
- Centre for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
- Department of Cardiovascular Medicine, Kyoto University Hospital, Kyoto, Japan.
- Centre for iPS Cell Research and Application, Kyoto University, Kyoto, Japan; Takeda-CiRA Joint program (T-CiRA), Fujisawa, Japan. Electronic address: yoshinor@cira.kyoto-u.ac.jp.
Förderung
- Takeda Pharmaceutical Company
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science London
- Fondation Leducq
- Japan Society for the Promotion of Science
Zitieren
APA
Kasamoto, M., Funakoshi, S., Hatani, T., Okubo, C., Nishi, Y., Tsujisaka, Y., Nishikawa, M., Narita, M., Ohta, A., Kimura, T., & Yoshida, Y. (2023). Am80, a retinoic acid receptor agonist, activates the cardiomyocyte cell cycle and enhances engraftment in the heart. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2023.06.006
Vancouver
Kasamoto M, Funakoshi S, Hatani T, Okubo C, Nishi Y, Tsujisaka Y, et al. Am80, a retinoic acid receptor agonist, activates the cardiomyocyte cell cycle and enhances engraftment in the heart. Stem Cell Reports. 2023. doi:10.1016/j.stemcr.2023.06.006
BibTeX
@article{Kasamoto2023,
author = {Kasamoto, Manabu and Funakoshi, Shunsuke and Hatani, Takeshi and Okubo, Chikako and Nishi, Yohei and Tsujisaka, Yuta and Nishikawa, Misato and Narita, Megumi and Ohta, Akira and Kimura, Takeshi and Yoshida, Yoshinori},
title = {Am80, a retinoic acid receptor agonist, activates the cardiomyocyte cell cycle and enhances engraftment in the heart},
journal = {Stem Cell Reports},
year = {2023},
doi = {10.1016/j.stemcr.2023.06.006}
}
EUVIMED